List of Oncology Medication For

Solid Tumors

Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.

Gefitinib Tablets

Lung Cancer

gefitinib tablets
for oral use Initial U.S. Approval: 2015

IRESSA is a tyrosine kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test.

Facts about gefitinib tablets

Approval Date: 2015
Proprietary Name: On Request
Active Ingredient(s): gefitinib tablets
Dosage Forms And Strengths: Tablets: 250 mg
Company: AstraZeneca
Current indications: non-small cell lung cancer (NSCLC)
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “gefitinib tablets” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Gemcitabine for injection

Ovarian, Bile Duct Cancer, Breast Cancer, Lung Cancer, Pancreatic

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Gemcitabine hydrochloride is a type of chemotherapy called an antimetabolite. It kills cancer cells and other rapidly growing cells by preventing them from making DNA and RNA.

Facts about Gemcitabine for injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): Gemcitabine for injection
Dosage Forms And Strengths: Capsules: • 200 mg/single-use vial • 1 g/single-use vial
Company: Eli Lilly and Company
Current indications: non-small cell lung cancer; NSCLC
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Gemcitabine for injection” based on the information you provide.

Glentek/Riluzol (riluzole)

Neuro

Glentek/Riluzol (riluzole)

Glentek is used in patients with amyotrophic lateral sclerosis ( ALS ). ALS is a type of motor neuron disease in which attacks the nerve cells, which are responsible for sending instructions to the muscles, leading to weakness, muscle wasting, and paralysis.

Brand Name:	Glentek/Riluzol
Generic Name:	riluzole
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Glentek/Riluzol (riluzole)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team forGlentek/Riluzol (riluzole) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Gomekli (Mirdametinib) Tablets

Neuro

Brand Name: Gomekli. Generic Name: (Mirdametinib). It is used to treat neurofibromatosis type 1 (NF1).

Gomekli is used to treat certain people with a condition called neurofibromatosis type 1 (NF1).

Brand Name:	Gomekli
Generic Name:	Mirdametinib
Strength:	•
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Gomekli (Mirdametinib) Tablets” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for pharma product cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Goserelin Acetate Implant

Prostate

goserelin acetate implant 3.6 mg Initial U.S. Approval: 1989

Goserelin implant is used in combination with radiation therapy and other medications to treat localized prostate cancer and is used alone to treat the symptoms associated with advanced prostate cancer. It is also used to treat advanced breast cancer in certain women.

Facts about goserelin acetate implant

Approval Date: 1998
Proprietary Name: On Request
Active Ingredient(s): goserelin acetate implant
Dosage Forms And Strengths: Implant 3.6 mg
Company: AstraZeneca
Current indications:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import goserelin acetate implant” based on the information you provide.

Guselkumab injection

Skin

guselkumab injection
for subcutaneous use Initial U.S. Approval: 2017

Facts about guselkumab injection

DISEASE INDICATIONS-Psoriasis
MANUFACTURER-Janssen Biotech
USAGE-Subcutaneous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “guselkumab injection” based on the information you provide.

IMDELLTRA (tarlatamab-dlle) for injection

Lung Cancer, Solid Tumors

Brand Name: IMDELLTRA Generic Name: tarlatamab-dlle IMDELLTRA (tarlatamab-dlle) is used to treat adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.

On May 16, 2024, the Food and Drug Administration granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen, Inc.) for extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.

Brand Name:	IMDELLTRA
Generic Name:	tarlatamab-dlle
Strength:	• 1 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution. • 10 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution.
Manufacturer:	Amgen Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “IMDELLTRA (tarlatamab-dlle)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for IMDELLTRA (tarlatamab-dlle) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Imetelstat for injection

MDS, Blood Disorders, Neuro

Salt Name: imetelstat. It is used to treat patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS).

RYTELO is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).

Generic Name:	imetelstat
Strength:	• For injection: 47 mg powder in a single-dose vial for reconstitution. • For injection: 188 mg powder in a single-dose vial for reconstitution.
Manufacturer:	Geron Corporation
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “RYTELO (imetelstat)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for RYTELO (imetelstat) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Ipilimumab Injection

Gastrointestinal, Skin

ipilimumab injection,
for intravenous use Initial U.S. Approval: 2011

Yervoy (ipilimumab) is a kinase inhibitor indicated for the treatment of advanced (unresectable or metastatic) melanoma.

Facts about Ipilimumab Injection

API: ipilimumab
Trade Name: On Request
Packaging: injection, for intravenous use
Strength: Injection: 50 mg/10 mL (5 mg/mL) and 200 mg/40 mL (5 mg/mL) in a single-use vial.
DISEASE INDICATIONS-Urothelial Carcinoma, Skin Cancer
MANUFACTURER-Bristol-Myers Squibb
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ipilimumab Injection” based on the information you provide.

Ixekizumab injection

Skin

ixekizumab injection
for subcutaneous use Initial U.S. Approval: 2016

ixekizumab injection is a humanized interleukin-17A antagonist indicated for the treatment of: • patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. • adults with active psoriatic arthritis. • adults with active ankylosing spondylitis. • adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.

Facts about ixekizumab injection

DISEASE INDICATIONS-Psoriasis
MANUFACTURER-Eli Lilly Nederland B.V.
USAGE-Subcutaneous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ixekizumab injection” based on the information you provide.

« Older Entries

Next Entries »

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Solid Tumors

gefitinib tablets for oral use Initial U.S. Approval: 2015

Facts about gefitinib tablets

Access the best support services globally

Gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Facts about Gemcitabine for injection

Access the best support services globally

Glentek/Riluzol (riluzole)

Brand Name: Gomekli. Generic Name: (Mirdametinib). It is used to treat neurofibromatosis type 1 (NF1).

goserelin acetate implant 3.6 mg Initial U.S. Approval: 1989

Facts about goserelin acetate implant

Access the best support services globally

guselkumab injection for subcutaneous use Initial U.S. Approval: 2017

Facts about guselkumab injection

Access the best support services globally

Brand Name: IMDELLTRA Generic Name: tarlatamab-dlle IMDELLTRA (tarlatamab-dlle) is used to treat adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.

Salt Name: imetelstat. It is used to treat patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS).

ipilimumab injection, for intravenous use Initial U.S. Approval: 2011

Facts about Ipilimumab Injection

Access the best support services globally

ixekizumab injection for subcutaneous use Initial U.S. Approval: 2016

Facts about ixekizumab injection

Access the best support services globally

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

gefitinib tablets
for oral use Initial U.S. Approval: 2015

guselkumab injection
for subcutaneous use Initial U.S. Approval: 2017

ipilimumab injection,
for intravenous use Initial U.S. Approval: 2011

ixekizumab injection
for subcutaneous use Initial U.S. Approval: 2016